Stifel Starts agilon health Inc (AGL) at Buy

Stifel analyst Craig Jones initiates coverage on agilon health Inc (NYSE: AGL) with a Buy rating and a price target of $23.00.

The analyst comments "agilon's platform enables established primary care provider groups to transition to value-based care by taking full risk on their Medicare Advantage patients. agilon offers relatively high exposure to the US healthcare transition to value-based care on a platform model that is very capex and opex light. We expect agilon to continue to grow 30%+ in the medium term while expanding margins and to begin generating cash in 2023, with $1 billion in cash and no debt on the balance sheet."

For an analyst ratings summary and ratings history on agilon health Inc click here. For more ratings news on agilon health Inc click here.

Shares of agilon health Inc closed at $17.08 yesterday.

You May Also Be Interested In

• Guggenheim remains bullish on WWE’s renewal cycle
• Mitsubishi Motors Corp. (7211:JP) (MMTOF) PT Lowered to JPY480 at Nomura/Instinet
• CDL Hospitality Trusts (CDREIT:SP) PT Raised to SGD1.40 at JPMorgan